Name
Dinner | Explore Data for an FDA-Approved Treatment Option in HR+, HER2- Breast Cancer in Certain Adjuvant or Metastatic Settings
Date & Time
Thursday, April 28, 2022, 6:35 PM - 7:35 PM
Description
Explore Data for an FDA-Approved Treatment Option in HR+, HER2- Breast Cancer in Certain Adjuvant or Metastatic Settings
Speaker: Rodney J. Hunter, PharmD, BCOP
Location Name
A706-A707